Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Cardiovascular Drug Reviews
|
January 12, 2007
Therapeutic use of citrulline in cardiovascular disease
Maritza J Romero, Daniel H Platt, Ruth B Caldwell, et al.
Free Radical Biology & Medicine
|
November 1, 2005
Peroxynitrite increases VEGF expression in vascular endothelial cells via STAT3
Daniel H Platt, Manuela Bartoli, Azza B El-Remessy, et al.
Diabetes/Metabolism Research and Reviews
|
December 4, 2003
Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives
Ruth B Caldwell, Manuela Bartoli, M Ali Behzadian, et al.
The American Journal of Pathology
|
July 29, 2005
Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy
Mohamed Al-Shabrawey, Manuela Bartoli, Azza B El-Remessy, et al.
Circulation Research
|
October 31, 2007
Diabetes-induced coronary vascular dysfunction involves increased arginase activity
Maritza J Romero, Daniel H Platt, Huda E Tawfik, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
November 8, 2011
Diabetes-induced vascular dysfunction involves arginase I
Maritza J Romero, Jennifer A Iddings, Daniel H Platt, et al.
Current Drug Targets
|
July 20, 2005
Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress
Ruth B Caldwell, Manuela Bartoli, M Ali Behzadian, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Cardiovascular Drug Reviews
|
January 12, 2007
Therapeutic use of citrulline in cardiovascular disease
Maritza J Romero, Daniel H Platt, Ruth B Caldwell, et al.
Free Radical Biology & Medicine
|
November 1, 2005
Peroxynitrite increases VEGF expression in vascular endothelial cells via STAT3
Daniel H Platt, Manuela Bartoli, Azza B El-Remessy, et al.
Diabetes/Metabolism Research and Reviews
|
December 4, 2003
Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives
Ruth B Caldwell, Manuela Bartoli, M Ali Behzadian, et al.
The American Journal of Pathology
|
July 29, 2005
Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy
Mohamed Al-Shabrawey, Manuela Bartoli, Azza B El-Remessy, et al.
Circulation Research
|
October 31, 2007
Diabetes-induced coronary vascular dysfunction involves increased arginase activity
Maritza J Romero, Daniel H Platt, Huda E Tawfik, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
November 8, 2011
Diabetes-induced vascular dysfunction involves arginase I
Maritza J Romero, Jennifer A Iddings, Daniel H Platt, et al.
Current Drug Targets
|
July 20, 2005
Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress
Ruth B Caldwell, Manuela Bartoli, M Ali Behzadian, et al.
Page
of 1